Cargando…

Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma

BACKGROUND: Discriminating between autoimmune pancreatitis (AIP), chronic pancreatitis (CP), and pancreatic ductal adenocarcinoma (PDAC) can be challenging. In this retrospective study, levels of serum and tissue cytokines were analyzed as part of the clinical strategy for the preoperative different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghassem-Zadeh, Sahar, Gaida, Matthias M., Szanyi, Szilard, Acha-Orbea, Hans, Frossard, Jean-Louis, Hinz, Ulf, Hackert, Thilo, Strobel, Oliver, Felix, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457650/ https://www.ncbi.nlm.nih.gov/pubmed/28578701 http://dx.doi.org/10.1186/s12967-017-1227-3

Ejemplares similares

Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach
por: Ghassem-Zadeh, Sahar, et al.
Publicado: (2020)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
por: Wei, Kongyuan, et al.
Publicado: (2021)

Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma
por: Xie, Li, et al.
Publicado: (2019)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Imaging features of intraductal tubulopapillary neoplasm of the pancreas and its differentiation from conventional pancreatic ductal adenocarcinoma
por: Khristenko, Ekaterina, et al.
Publicado: (2022)

Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis
por: Yanagisawa, Kiyoshi, et al.
Publicado: (2012)

C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms
por: Nießen, Anna, et al.
Publicado: (2021)

Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer
por: Roth, Susanne, et al.
Publicado: (2020)

Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10
por: Stern, Louisa, et al.
Publicado: (2018)

Diffuse-Type Pancreatic Ductal Adenocarcinoma Mimicking Autoimmune Pancreatitis
por: Chow, Kenneth W., et al.
Publicado: (2023)

Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer
por: Hank, Thomas, et al.
Publicado: (2023)

Delayed pancreatic ductal leakage after EUS-FNA for autoimmune pancreatitis
por: Ikarashi, Satoshi, et al.
Publicado: (2019)

Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: Caba, Octavio, et al.
Publicado: (2023)

Diffusion Kurtosis Imaging—A Superior Approach to Assess Tumor–Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Mayer, Philipp, et al.
Publicado: (2020)

Recent advances in the management of autoimmune pancreatitis in the era of artificial intelligence
por: Mack, Sahar, et al.
Publicado: (2022)

Deep Learning in Pancreatic Tissue: Identification of Anatomical Structures, Pancreatic Intraepithelial Neoplasia, and Ductal Adenocarcinoma
por: Kriegsmann, Mark, et al.
Publicado: (2021)

Neurotensin receptors in pancreatic ductal carcinomas
por: Körner, Meike, et al.
Publicado: (2015)

Serum Protein Signatures Differentiating Autoimmune Pancreatitis versus Pancreatic Cancer
por: Felix, Klaus, et al.
Publicado: (2013)

Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression
por: Alam, Muhammad S., et al.
Publicado: (2015)

Objective parameters aid the prediction of fistulas in pancreatic surgery
por: FELIX, KLAUS, et al.
Publicado: (2014)

The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing
por: Zhou, Wenli, et al.
Publicado: (2021)

Surgery for Pancreatic Cancer after neoadjuvant treatment
por: Hackert, Thilo
Publicado: (2018)

State-of-the-art surgery for pancreatic cancer
por: Nießen, Anna, et al.
Publicado: (2021)

Enormously dilated pancreatic duct
por: Koschny, Ronald, et al.
Publicado: (2022)

High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylation
por: Shih, Hsi-Chang, et al.
Publicado: (2019)

Deep Convolutional Neural Network-Assisted Feature Extraction for Diagnostic Discrimination and Feature Visualization in Pancreatic Ductal Adenocarcinoma (PDAC) versus Autoimmune Pancreatitis (AIP)
por: Ziegelmayer, Sebastian, et al.
Publicado: (2020)

Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis
por: Uchida, Kazushige, et al.
Publicado: (2018)

Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial
por: Lozanovski, Vladimir J, et al.
Publicado: (2014)

Actinin-4 splice variant - a complementary diagnostic and prognostic marker of pancreatic neuroendocrine neoplasms
por: Xu, Xiaojun, et al.
Publicado: (2020)

Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
por: Zhang, Yiyao, et al.
Publicado: (2015)

Cystathionine β-synthase overexpression drives metastatic dissemination in pancreatic ductal adenocarcinoma via inducing epithelial-to-mesenchymal transformation of cancer cells
por: Czikora, Ágnes, et al.
Publicado: (2022)

Biliary Involvement in Type 2 Autoimmune Pancreatitis
por: Ollo, Diana, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma and Pancreatic Tumor Cell Lines: The Role of Neutrophils and Neutrophil-Derived Elastase
por: Große-Steffen, Thomas, et al.
Publicado: (2012)

Adenosine in pancreatic cancer: Emerging combination therapies
por: Roth, Susanne, et al.
Publicado: (2019)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: He, Chaobin, et al.
Publicado: (2019)

Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma
por: Jia, Huihui, et al.
Publicado: (2021)

Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
por: Deng, Yan, et al.
Publicado: (2021)

Pancreatic Tuberculosis or Autoimmune Pancreatitis
por: Salahuddin, Ayesha, et al.
Publicado: (2014)

Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma
por: Mustafa, Shakhawan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_30j0746psmagp3r3v5bcmi3r1b